- Home
- NREF vs XOMA Comparison
NREF vs XOMA Comparison
Compare NREF & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NREF
- XOMA
- Stock Information
- Founded
- NREF 2019
- XOMA 1981
- Country
- NREF United States
- XOMA United States
- Employees
- NREF N/A
- XOMA N/A
- Industry
- NREF Real Estate Investment Trusts
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- NREF Real Estate
- XOMA Health Care
- Exchange
- NREF Nasdaq
- XOMA Nasdaq
- Market Cap
- NREF 310.3M
- XOMA 355.6M
- IPO Year
- NREF 2020
- XOMA N/A
- Fundamental
- Price
- NREF $15.67
- XOMA $26.76
- Analyst Decision
- NREF Hold
- XOMA Strong Buy
- Analyst Count
- NREF 4
- XOMA 2
- Target Price
- NREF $14.75
- XOMA $81.50
- AVG Volume (30 Days)
- NREF 43.6K
- XOMA 36.4K
- Earning Date
- NREF 02-27-2025
- XOMA 03-07-2025
- Dividend Yield
- NREF 12.76%
- XOMA N/A
- EPS Growth
- NREF N/A
- XOMA N/A
- EPS
- NREF 1.32
- XOMA N/A
- Revenue
- NREF $73,164,000.00
- XOMA $21,606,000.00
- Revenue This Year
- NREF N/A
- XOMA $511.48
- Revenue Next Year
- NREF $34.61
- XOMA $26.91
- P/E Ratio
- NREF $11.84
- XOMA N/A
- Revenue Growth
- NREF 224.04
- XOMA 389.82
- 52 Week Low
- NREF $12.63
- XOMA $18.57
- 52 Week High
- NREF $18.09
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- NREF 47.65
- XOMA 47.49
- Support Level
- NREF $14.50
- XOMA $23.88
- Resistance Level
- NREF $15.75
- XOMA $29.02
- Average True Range (ATR)
- NREF 0.46
- XOMA 1.27
- MACD
- NREF 0.03
- XOMA 0.27
- Stochastic Oscillator
- NREF 78.13
- XOMA 56.03
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a real estate investment trust. It provides structured financing solutions by investing in mid-sized multifamily, storage and select-service, and extended-stay hospitality properties. Its investment objective is to generate attractive, risk-adjusted returns for stockholders over the long term. The Company is focused on originating, structuring and investing in first-lien mortgage loans, mezzanine loans, preferred equity, convertible notes, multifamily properties, and common equity investments, as well as multi-family and single-family rental ("SFR") commercial mortgage-backed securities securitizations ("CMBS securitizations"), multifamily structured credit risk notes ("MSCR Notes") and mortgage-backed securities.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.